New USP Chapter on Cured Silicone Components
![GMP Pre-sterilized Packaging Material - Live Online Training](files/eca/userImages/training.img/Z-ECA-Pre-Sterilized-Packaging-Material-Live-Online-Training.jpg)
Recommendation
Thursday, 14 November 2024 9 .00 - 17.15 h
Requirements and Challenges for RTU / RTS Products
Following the draft chapter on Elastomers for Pharmaceutical Packaging and Manufacturing that was published for comment in Pharmacopeial Forum (PF) 48(3), the final text for USP <383> Cured Silicone Elastomers for Pharmaceutical Packaging and Manufacturing Components has been published in the USP. The chapter will become official on 1 December 2027. Early adoption of the requirements in this chapter is permitted by USP.
Cured silicone components are used as elastomeric closures for pharmaceutical packaging and also as components in manufacturing operations for drug substances and drug products. The chapter is applicable to elastomeric components such as diaphragms, gaskets, O-rings, and tubing. Silicone elastomers are obtained by cross-linking (curing) a linear polysiloxane constructed mainly of dimethylsiloxy units with small quantities of methylvinylsiloxy groups, where the chain ends are blocked by trimethylsiloxy or dimethylvinylsiloxy groups. The cross-linking is usually carried out via high-temperature vulcanization, either by a free-radical reaction using organic peroxides, or by an addition reaction using platinum as a catalyst. However, in all cases, appropriate additives such as silica are used. Organosilicon additives (e.g., dihydroxy polydimethylsiloxane) can also be used in small quantities.
More information is available in the USP.
Related GMP News
05.06.2024Requirements for Sterile Packaging Material
07.12.2023First Electronic Product Information (ePI) for Human Medicines
26.10.2023Revised USP Chapter <660> Glass Containers
19.07.2023Auxiliary Packaging Components
11.07.2023How to determine the Protective Properties of Amber Glass Containers?